MARTINELLI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.200
AS - Asia 819
EU - Europa 602
SA - Sud America 132
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 44
OC - Oceania 4
Totale 2.868
Nazione #
US - Stati Uniti d'America 1.163
CN - Cina 239
SG - Singapore 211
IE - Irlanda 171
BR - Brasile 109
HK - Hong Kong 104
RU - Federazione Russa 103
VN - Vietnam 102
IT - Italia 69
DE - Germania 61
FI - Finlandia 58
FR - Francia 42
GB - Regno Unito 36
BD - Bangladesh 32
IN - India 30
ZA - Sudafrica 24
CA - Canada 16
ID - Indonesia 12
TR - Turchia 12
AT - Austria 11
JP - Giappone 11
MX - Messico 11
IQ - Iraq 9
AR - Argentina 8
ES - Italia 8
PH - Filippine 8
PL - Polonia 8
UZ - Uzbekistan 8
NL - Olanda 7
MA - Marocco 6
SA - Arabia Saudita 6
EG - Egitto 5
IL - Israele 5
MY - Malesia 5
SE - Svezia 5
CO - Colombia 4
PK - Pakistan 4
AU - Australia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
PE - Perù 3
TW - Taiwan 3
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
UA - Ucraina 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CM - Camerun 1
GE - Georgia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 2.801
Città #
Dublin 171
San Jose 139
Chandler 128
Ashburn 123
Dallas 114
Singapore 110
Hong Kong 99
Beijing 63
Council Bluffs 48
Los Angeles 47
Boardman 43
New York 41
Helsinki 37
Lauterbourg 31
Ho Chi Minh City 29
Munich 25
Hanoi 22
Shanghai 22
Johannesburg 21
Lawrence 21
Princeton 21
Turku 21
Medford 20
Moscow 20
Nanjing 20
Buffalo 15
Orem 14
Redondo Beach 12
Frankfurt am Main 11
Rome 11
Santa Clara 11
São Paulo 11
Shenyang 10
The Dalles 10
Tokyo 10
Brooklyn 9
Milan 9
Nanchang 9
Wilmington 9
Changsha 8
Chennai 8
Columbus 8
Denver 8
Tashkent 8
Chicago 7
Haiphong 7
London 7
Pavia 7
Phoenix 7
Atlanta 6
Baghdad 6
Da Nang 6
Mexico City 6
Warsaw 6
Brasília 5
Cagliari 5
City of London 5
Figino 5
Istanbul 5
Norwalk 5
Poplar 5
San Francisco 5
Stockholm 5
Vienna 5
Boston 4
Cairo 4
Hebei 4
Houston 4
Jakarta 4
Manchester 4
Manila 4
Montreal 4
Rio de Janeiro 4
Riyadh 4
Washington 4
Athens 3
Barcelona 3
Belo Horizonte 3
Bến Tre 3
Campinas 3
Chandigarh 3
Cremona 3
Dhaka 3
Guangzhou 3
Hangzhou 3
Hefei 3
Jiaxing 3
Kunming 3
Mumbai 3
New Delhi 3
Nuremberg 3
Portsmouth 3
Redwood City 3
Seattle 3
Shenzhen 3
Tianjin 3
Toronto 3
Vancouver 3
Woodbridge 3
Addis Ababa 2
Totale 1.860
Nome #
Functional and structural MRI signature of the induced migraine attack 160
A machine learning approach for the differential diagnosis of Alzheimer and vascular dementia fed by MRI selected features. 146
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm 130
Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial 115
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 113
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 111
Frontal and cerebellar atrophy supports FTSD-ALS clinical continuum 109
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 102
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 101
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 101
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults 99
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 96
Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings 95
Chronic migraine and Botulinum Toxin Type A: Where do paths cross? 91
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 91
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 89
Migraine neuroscience: from experimental models to target therapy 85
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial 85
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 84
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: Additional findings from the randomized, sham-controlled, double-blind PRESTO trial 11 Medical and Health Sciences 1103 Clinical Sciences 83
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 82
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 82
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study 81
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults 78
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine 71
Lasmiditan: an additional therapeutic option for the acute treatment of migraine 69
Peripheral vagal nerve stimulation modulates the nociceptive withdrawal reflex in healthy subjects: A randomized, cross-over, sham-controlled study 65
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 59
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches 58
Thalamocortical connectivity in experimentally-induced migraine attacks: A pilot study 50
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 36
null 11
miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells 9
Childhood traumas delineate a distinct psychological and clinical profile in adults with migraine: The hidden burden 7
Real world effectiveness of anti-CGRP monoclonal antibodies over three consecutive one-year treatment cycles: An intention-to-treat analysis 7
Advances in migraine prevention 5
The regional outreach programme of the International Headache Society: A WHO-IGAP oriented programme to improve access to care for headache patients in sub-Saharan Africa 3
Exploring the Association of Migraine Susceptibility SNPs With the Risk of Chronic Migraine 2
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 2
International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine 2
Efficacy of traditional swallowing therapy plus neuromuscular electrostimulation in multiple sclerosis: A randomized controlled trial 2
Evidence-based guidelines for the pharmacological treatment of migraine 1
Totale 2.868
Categoria #
all - tutte 13.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202271 0 1 1 0 0 0 0 10 3 0 9 47
2022/2023375 36 36 1 32 28 28 1 14 180 6 11 2
2023/2024204 34 20 8 17 19 38 4 20 4 10 8 22
2024/2025653 23 34 21 9 28 63 72 21 157 38 82 105
2025/20261.328 117 70 150 125 158 54 256 72 120 98 74 34
2026/2027121 62 59 0 0 0 0 0 0 0 0 0 0
Totale 2.868